Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis
Nathan D. Mathewson, Orr Ashenberg, Itay Tirosh, Simon Gritsch, Elizabeth M. Perez, Sascha Marx, Livnat Jerby‐Arnon, Rony Chanoch-Myers, Toshiro Hara, Alyssa Richman, Yoshinaga Ito, Jason W. Pyrdol, Mirco Friedrich, Kathrin Schumann, Michael J. Poitras, Prafulla C. Gokhale, L. Nicolas Gonzalez Castro, Marni E. Shore, Christine Hebert, Brian Shaw, Heather L. Cahill, Matthew Drummond, Wubing Zhang, Olamide Olawoyin, Hiroaki Wakimoto, Orit Rozenblatt–Rosen, Priscilla K. Brastianos, Xia Liu, Pamela S. Jones, Daniel P. Cahill, Matthew P. Frosch, David N. Louis, Gordon J. Freeman, Keith L. Ligon, Alexander Marson, E. Antonio Chiocca, David A. Reardon, Aviv Regev, Mario L. Suvà, Kai W. Wucherpfennig
Topics & Concepts
BiologyGliomaCytotoxic T cellImmunotherapyCancer researchT cellImmunologyImmune systemGeneticsIn vitroImmune Cell Function and InteractionCAR-T cell therapy researchT-cell and B-cell Immunology